zhigong Biomedicine

zhigong Biomedicine

Blog

Information Details

From September 22 to 24, 2023, the 49th China International Medical Equipment (Shandong) Expo successfully concluded at the Shandong International Convention and Exhibition Center in Jinan. The event drew more than 1,200 renowned companies from across the industry, with numerous brand‑name products from Fortune Global 500 firms making their debut. With the theme “Caring for Life, Safeguarding Health,” the three‑day expo showcased cutting‑edge innovations and solutions in the medical device sector.

Release Date:

2023-09-25

From September 22 to 24, 2023, the 49th China International Medical Equipment (Shandong) Expo successfully concluded at the Shandong International Convention and Exhibition Center in Jinan. The event drew more than 1,200 renowned companies from across the industry, with numerous brand‑name products from Fortune Global 500 firms making their debut. With the theme “Caring for Life, Safeguarding Health,” the three‑day expo showcased cutting‑edge innovations and solutions in the medical device sector.

From September 22 to 24, 2023, the 49th China International Medical Equipment (Shandong) Expo successfully concluded at the Shandong International Convention and Exhibition Center in Jinan. This year’s event attracted… Introduced More than 1,200 well-known companies from across the industry are participating, with brand-name products from numerous Fortune Global 500 firms also on display. The exhibition’s theme is “Caring for Life, Protecting Health,” and it will run for three days.

As a flagship event under the “2023 Shandong International Big Health Industry Expo,” this expo boasts high standards and broad industry coverage. At the event, Yantai Zhigong Bio engaged in direct, face-to-face exchanges with exhibitors, visitors, and experts, exploring market opportunities, sharing insights, and discussing emerging markets and trends in the IVD sector.

Meanwhile, Yantai Zhigong Biopharmaceutical Technology Co., Ltd. has been providing attentive, professional, and enthusiastic explanations to every visitor, striving to deliver an exceptional exhibition experience. Looking ahead, Zhigong Bio will continue to align with market demands, pursue rigorous research, and consistently develop higher‑value products and services for its customers, jointly exploring new business opportunities and building a win‑win future.

Previous page

Next page

Previous page

Next page

Latest Updates

Good News | Zhigong Bio’s NTSPECTOF 9600 Fully Automated Nucleic Acid Mass Spectrometry Platform Has Been Certified!

Good News | Zhigong Bio’s NTSPECTOF 9600 Fully Automated Nucleic Acid Mass Spectrometry Platform Has Been Certified!

With approval from the Shandong Provincial Medical Products Administration, the “Fully Automated Time-of-Flight Mass Spectrometry Detection System,” independently developed by Yantai Zhigong Biopharmaceutical Technology Co., Ltd., obtained a Class II medical device registration certificate on May 11, 2026, under registration number Lu Xie Zhu Jun 20262220159.

Deepening University–Enterprise Collaboration to Jointly Promote Technology Transfer: An Expert Team from Shandong University of Traditional Chinese Medicine Conducts a Research and Exchange Visit to Yantai Zhigong Biopharmaceutical Technology Co., Ltd.

Deepening University–Enterprise Collaboration to Jointly Promote Technology Transfer: An Expert Team from Shandong University of Traditional Chinese Medicine Conducts a Research and Exchange Visit to Yantai Zhigong Biopharmaceutical Technology Co., Ltd.

On the afternoon of April 2, a multidisciplinary team of experts led by Cheng Kai from the Science and Technology Office of Shandong University of Traditional Chinese Medicine—including Professors Xu Yuxue, Yang Linlin, and Bi Liyan—visited Yantai Zhigong Biopharmaceutical Technology Co., Ltd. (hereinafter referred to as “Yantai Zhigong”) to conduct an on-site research visit and hold cooperative discussions.

Zhigong Bio Concludes at the 2026 CACLP Exhibition | The Highlights Don’t End Here—The Future Looks Promising!

Zhigong Bio Concludes at the 2026 CACLP Exhibition | The Highlights Don’t End Here—The Future Looks Promising!

On March 23, the 23rd CACLP, which drew global attention to the IVD industry, concluded successfully at the Xiamen International Exhibition Center. This year’s event, themed “Moving Forward with Innovation, Achieving Long-Term Success through Quality,” brought together over 1,000 companies spanning the entire IVD value chain from around the world. Zhugong Bio made a striking appearance with its core product portfolio, closing the show on a strong note and earning widespread attention and high praise from industry peers.

Good News | Zhigong Bio Wins the “Technological Innovation Award” at the National Unicorn Enterprise Competition

Good News | Zhigong Bio Wins the “Technological Innovation Award” at the National Unicorn Enterprise Competition

On December 14, the finals of the 2025 National Unicorn Enterprise Competition concluded successfully in Ningbo High-tech Zone. Yantai Zhigong Biopharmaceutical Technology Co., Ltd. stood out among nearly 140 shortlisted companies recommended by expert panels nationwide, thanks to its groundbreaking technological advances in the biopharmaceutical field. The company was awarded the “Technological Innovation Award” in this competition, earning a highly prestigious accolade for Yantai’s biopharmaceutical industry.

Good News: Zhigong Bio’s Three Innovative Pioneers Have Secured Malaysia’s “Passport” for the First Time

Good News: Zhigong Bio’s Three Innovative Pioneers Have Secured Malaysia’s “Passport” for the First Time

As China and the Malaysian governments deepen their cooperation on mutual recognition of medical device regulatory systems, leading Chinese medical device companies are seizing unprecedented opportunities for international expansion.

Chen Dexin Conducts a Field Inspection of Science and Technology Innovation and the Commercialization of Research Outcomes

Chen Dexin Conducts a Field Inspection of Science and Technology Innovation and the Commercialization of Research Outcomes

On January 11, Vice Governor Chen Dexin, during a field visit to the Silk Road International Intellectual Property Port and other enterprises, emphasized the need to thoroughly implement the spirit of the Central Economic Work Conference, earnestly carry out the arrangements and requirements set forth at the Fourth Plenary Session of the 14th Provincial Party Committee and the Provincial Economic Work Conference, and deepen the integrated development of technological innovation and industrial innovation. He called for further strengthening enterprises as the main actors, bolstering platform support, and improving innovation‑related services, so as to promote the synergistic integration and mutual reinforcement of the innovation chain, industrial chain, financial chain, and talent chain, thereby building momentum and empowering high‑quality industrial development through advanced scientific and technological innovation.

+86-535-8209310

Yantai Zhigong Biomedicine Technology Co., Ltd.

Phone:+86-535-8209310

Email:zhigonggent@126.com

Address: Floor 9, Building 9, Shandong International Biotechnology Park, No. 39, Science Avenue, High-tech Zone, Yantai City, Shandong Province

WeChat Official Account

© Zhigong Biomedicine

Powered by: 300.cn